| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.83 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.64 | 3e-06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.47 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.46 | 0.003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.44 | 0.05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.36 | 3e-07 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.35 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.35 | 2e-05 |